ARCHIVES

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

This article is from The Cancer Letter archive.

Vol. 02 No. 13 | March 26, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

NCI Gets Concept Approval for New Communications Network

May 27, 1988